Aptose Biosciences
(NASDAQ:APTO)
$0.5765
-0.0175[-2.95%]
At close: Sep 29
$0.62
0.0435[7.55%]
After Hours: 6:58PM EDT
Day Range0.57 - 0.6152 Wk Range0.54 - 1.55Open / Close0.59 / 0.58Float / Outstanding91M / 92.3M
Vol / Avg.107.3K / 193.6KMkt Cap53.2MP/E-50d Avg. Price0.76
Div / Yield-Payout Ratio-Total Float91MEPS-0.11

Aptose Biosciences Stock (NASDAQ:APTO), Quotes and News Summary

Aptose Biosciences Stock (NASDAQ: APTO)

Day Range0.57 - 0.6152 Wk Range0.54 - 1.55Open / Close0.59 / 0.58Float / Outstanding91M / 92.3M
Vol / Avg.107.3K / 193.6KMkt Cap53.2MP/E-50d Avg. Price0.76
Div / Yield-Payout Ratio-Total Float91MEPS-0.11
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-10
REV
Q2 2022Est.ActualSurprise
EPS-0.130-0.110 0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aptose Biosciences Questions & Answers

Q
How do I buy Aptose Biosciences (APTO) stock?
A

You can purchase shares of Aptose Biosciences (NASDAQ: APTO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Aptose Biosciences's (APTO) competitors?
A

There are no as such competitors for Aptose Biosciences.

Q
What is the target price for Aptose Biosciences (APTO) stock?
A

The latest price target for Aptose Biosciences (NASDAQ: APTO) was reported by RBC Capital on Tuesday, May 10, 2022. The analyst firm set a price target for 6.00 expecting APTO to rise to within 12 months (a possible 940.76% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Aptose Biosciences (APTO)?
A

The stock price for Aptose Biosciences (NASDAQ: APTO) is $0.5765 last updated September 29, 2022, 8:00 PM UTC.

Q
Does Aptose Biosciences (APTO) pay a dividend?
A

There are no upcoming dividends for Aptose Biosciences.

Q
When is Aptose Biosciences (NASDAQ:APTO) reporting earnings?
A

Aptose Biosciences’s Q3 earnings are confirmed for Thursday, November 10, 2022.

Q
Is Aptose Biosciences (APTO) going to split?
A

There is no upcoming split for Aptose Biosciences.

Q
What sector and industry does Aptose Biosciences (APTO) operate in?
A

Aptose Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.